These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 31333791)
41. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772 [TBL] [Abstract][Full Text] [Related]
42. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
43. Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma. You N; Tan Y; Zhou L; Huang X; Wang W; Wang L; Wu K; Mi N; Li J; Zheng L Exp Cell Res; 2017 Sep; 358(2):217-226. PubMed ID: 28663060 [TBL] [Abstract][Full Text] [Related]
44. Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma. Chen CL; Wang Y; Pan QZ; Tang Y; Wang QJ; Pan K; Huang LX; He J; Zhao JJ; Jiang SS; Zhang XF; Zhang HX; Zhou ZQ; Weng de S; Xia JC Oncotarget; 2016 Mar; 7(13):16248-61. PubMed ID: 26919247 [TBL] [Abstract][Full Text] [Related]
45. Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma. Li A; Yan Q; Zhao X; Zhong J; Yang H; Feng Z; Du Y; Wang Y; Wang Z; Wang H; Zhou Y; Liu S; Nie Y Oncotarget; 2016 Jan; 7(1):524-37. PubMed ID: 26594798 [TBL] [Abstract][Full Text] [Related]
46. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma. Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928 [TBL] [Abstract][Full Text] [Related]
48. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186 [TBL] [Abstract][Full Text] [Related]
49. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1. Kan H; Huang Y; Li X; Liu D; Chen J; Shu M Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361 [TBL] [Abstract][Full Text] [Related]
50. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
51. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma. Yan TH; Qiu C; Sun J; Li WH Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3038-3046. PubMed ID: 29863248 [TBL] [Abstract][Full Text] [Related]
52. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1. Du X; Fan W; Chen Y Gene; 2018 May; 657():30-38. PubMed ID: 29505836 [TBL] [Abstract][Full Text] [Related]
53. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway. Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171 [TBL] [Abstract][Full Text] [Related]
54. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224 [TBL] [Abstract][Full Text] [Related]
55. Expression and prognostic value of ING3 in human primary hepatocellular carcinoma. Yang HY; Liu HL; Tian LT; Song RP; Song X; Yin DL; Liang YJ; Qu LD; Jiang HC; Liu JR; Liu LX Exp Biol Med (Maywood); 2012 Apr; 237(4):352-61. PubMed ID: 22550337 [TBL] [Abstract][Full Text] [Related]
56. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4. Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076 [TBL] [Abstract][Full Text] [Related]
57. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma. Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347 [TBL] [Abstract][Full Text] [Related]
58. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway. Zhang JG; Shi Y; Hong DF; Song M; Huang D; Wang CY; Zhao G Sci Rep; 2015 Jan; 5():8087. PubMed ID: 25627001 [TBL] [Abstract][Full Text] [Related]
59. LAPTM4B facilitates tumor growth and induces autophagy in hepatocellular carcinoma. Wang F; Wu H; Zhang S; Lu J; Lu Y; Zhan P; Fang Q; Wang F; Zhang X; Xie C; Yin Z Cancer Manag Res; 2019; 11():2485-2497. PubMed ID: 31118766 [No Abstract] [Full Text] [Related]
60. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]